PETER S RINGROSE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER S RINGROSE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER S RINGROSE. PETER S RINGROSE is Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in Theravance Biopharma, Inc. ($TBPH).
Latest Insider Trading Transactions of PETER S RINGROSE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 02 2019 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Option Exercise | A | 23.85 | 6,000 | 143,100 | 6,000 | |
May 02 2019 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Grant | A | 0.00 | 8,385 | 0 | 37,999 | 29.6 K to 38 K (+28.31 %) |
May 18 2018 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 3.98 | 40,000 | 159,200 | 40,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Option Exercise | A | 24.43 | 6,000 | 146,580 | 6,000 | |
May 03 2018 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Grant | A | 0.00 | 8,186 | 0 | 29,614 | 21.4 K to 29.6 K (+38.20 %) |
May 18 2017 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Grant | A | 0.00 | 6,000 | 0 | 21,428 | 15.4 K to 21.4 K (+38.89 %) |
May 12 2017 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 2.61 | 40,000 | 104,400 | 40,000 | |
May 12 2016 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 2.40 | 40,000 | 96,000 | 40,000 | |
May 05 2016 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Grant | A | 0.00 | 6,000 | 0 | 15,428 | 9.4 K to 15.4 K (+63.64 %) |
May 14 2015 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 3.96 | 40,000 | 158,400 | 40,000 | |
Apr 24 2015 | TBPH | Theravance Biophar ... | RINGROSE PETER S | Director | Grant | A | 0.00 | 6,000 | 0 | 9,428 | 3.4 K to 9.4 K (+175.03 %) |
May 29 2009 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 8.12 | 10,000 | 81,200 | 10,000 | |
May 30 2008 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 23.10 | 10,000 | 231,000 | 10,000 | |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
Jun 01 2007 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 9.74 | 10,000 | 97,400 | 10,000 | |
May 31 2006 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 9.93 | 10,000 | 99,300 | 10,000 | |
Jun 03 2005 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 17.41 | 10,000 | 174,100 | 10,000 | |
Feb 04 2005 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 19.30 | 6,667 | 128,673 | 6,667 | |
Feb 04 2005 | RIGL | RIGEL PHARMACEUTIC ... | RINGROSE PETER S | Director | Option Exercise | A | 19.30 | 13,333 | 257,327 | 13,333 |
Page: 1